Kentaro Watanabe

A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder.

S. Madoiwa, K. Kokame, M. Murata, 2021, Blood advances.

Novel TENM3–ALK fusion is an alternate mechanism for ALK activation in neuroblastoma

S. Miyano, S. Ogawa, Motohiro Kato, 2022, Oncogene.

Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia

Nicola K. Wilson, H. Aburatani, B. Göttgens, 2022, Nature Communications.

Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

H. Aburatani, S. Miyano, Hiromichi Suzuki, 2022, Oncogene.

Rare evolution of CSF3R-mutated chronic neutrophilic leukemia to t(4;12)(q12;p13) acute myeloid leukemia with SETBP1 mutation

S. Okamoto, M. Osada, T. Kikuchi, 2022, Leukemia research reports.

Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets

S. Miyano, Y. Shiraishi, K. Chiba, 2020, Communications Biology.

Predictors of parental distress during acute phase of pediatric hematopoietic stem cell transplantation in Japan: A multicenter prospective study

J. Takita, K. Kamibeppu, K. Koh, 2019, Blood cell therapy.